HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,649 | -5.8% | 44,623 | -2.6% | 0.79% | -12.3% |
| Q3 2023 | $1,750 | +3.9% | 45,806 | -1.9% | 0.90% | +9.9% |
| Q2 2023 | $1,684 | -6.5% | 46,685 | -1.0% | 0.82% | -10.8% |
| Q1 2023 | $1,801 | +20.5% | 47,169 | +79.7% | 0.92% | +17.4% |
| Q4 2022 | $1,494 | -99.9% | 26,249 | -8.1% | 0.78% | +27.8% |
| Q3 2022 | $1,130,000 | -10.0% | 28,574 | +0.2% | 0.61% | -1.8% |
| Q2 2022 | $1,255,000 | +7.0% | 28,512 | -3.1% | 0.62% | +25.2% |
| Q1 2022 | $1,173,000 | -2.6% | 29,422 | -1.8% | 0.50% | +2.9% |
| Q4 2021 | $1,204,000 | -2.5% | 29,947 | -1.3% | 0.48% | -3.2% |
| Q3 2021 | $1,235,000 | -11.3% | 30,350 | -9.2% | 0.50% | -10.1% |
| Q1 2021 | $1,393,000 | -1.8% | 33,411 | +0.5% | 0.56% | -16.8% |
| Q4 2020 | $1,419,000 | – | 33,233 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |